These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 1434126

  • 1. Ca2+ influx induced by the agonist U46619 is inhibited by hyperpolarization induced by the K+ channel opener cromakalim in canine coronary artery.
    Yamagishi T, Yanagisawa T, Taira N.
    Jpn J Pharmacol; 1992 Jul; 59(3):291-9. PubMed ID: 1434126
    [Abstract] [Full Text] [Related]

  • 2. Hyperpolarization induced by K+ channel openers inhibits Ca2+ influx and Ca2+ release in coronary artery.
    Yanagisawa T, Yamagishi T, Okada Y.
    Cardiovasc Drugs Ther; 1993 Aug; 7 Suppl 3():565-74. PubMed ID: 8251426
    [Abstract] [Full Text] [Related]

  • 3. K+ channel openers, cromakalim and Ki4032, inhibit agonist-induced Ca2+ release in canine coronary artery.
    Yamagishi T, Yanagisawa T, Taira N.
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Dec; 346(6):691-700. PubMed ID: 1484567
    [Abstract] [Full Text] [Related]

  • 4. Activation of phospholipase C by the agonist U46619 is inhibited by cromakalim-induced hyperpolarization in porcine coronary artery.
    Yamagishi T, Yanagisawa T, Taira N.
    Biochem Biophys Res Commun; 1992 Sep 30; 187(3):1517-22. PubMed ID: 1417828
    [Abstract] [Full Text] [Related]

  • 5. Differential vasorelaxant effects of K(+)-channel openers and Ca(2+)-channel blockers on canine isolated arteries.
    Iwamoto T, Nishimura N, Morita T, Sukamoto T.
    J Pharm Pharmacol; 1993 Apr 30; 45(4):292-7. PubMed ID: 8098370
    [Abstract] [Full Text] [Related]

  • 6. Differential antagonism by glibenclamide of the relaxant effects of cromakalim, pinacidil and nicorandil on canine large coronary arteries.
    Satoh K, Yamada H, Taira N.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan 30; 343(1):76-82. PubMed ID: 1827660
    [Abstract] [Full Text] [Related]

  • 7. Analysis of relaxation and repolarization mechanisms of nicorandil in rat mesenteric artery.
    Fujiwara T, Angus JA.
    Br J Pharmacol; 1996 Dec 30; 119(8):1549-56. PubMed ID: 8982500
    [Abstract] [Full Text] [Related]

  • 8. Effect of Kil769, a novel K(+)-channel opener, on sensitivity to Ca2+ of contractile elements and inositol phosphate formation in porcine coronary artery.
    Yokoyama T, Kasai H, Okada Y, Izumi H, Izawa T, Ogawa N.
    J Pharm Pharmacol; 1995 Feb 30; 47(2):148-51. PubMed ID: 7602470
    [Abstract] [Full Text] [Related]

  • 9. Cytoplasmic calcium and the relaxation of canine coronary arterial smooth muscle produced by cromakalim, pinacidil and nicorandil.
    Yanagisawa T, Teshigawara T, Taira N.
    Br J Pharmacol; 1990 Sep 30; 101(1):157-65. PubMed ID: 2149290
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. K+ channel-opening action contributes to the preventive effects of nicorandil on U46619-induced vasoconstriction of canine large coronary arteries in vivo.
    Kamijo T, Iwai T, Haruta K, Takeda K.
    Arch Int Pharmacodyn Ther; 1996 Sep 30; 331(3):273-84. PubMed ID: 9124999
    [Abstract] [Full Text] [Related]

  • 12. The mechanisms of the relaxation induced by vasoactive intestinal peptide in the porcine coronary artery.
    Kawasaki J, Kobayashi S, Miyagi Y, Nishimura J, Fujishima M, Kanaide H.
    Br J Pharmacol; 1997 Jul 30; 121(5):977-85. PubMed ID: 9222556
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparative study of vasodilator effects of the potassium channel openers NIP-121 and levcromakalim in dogs and rats.
    Yamashita T, Masuda Y, Kawamura N, Fujikura N, Tanaka S.
    Jpn J Pharmacol; 1995 Jun 30; 68(2):145-52. PubMed ID: 7563971
    [Abstract] [Full Text] [Related]

  • 15. BRL 38227 (levcromakalim)-induced hyperpolarization reduces the sensitivity to Ca2+ of contractile elements in canine coronary artery.
    Okada Y, Yanagisawa T, Taira N.
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Apr 30; 347(4):438-44. PubMed ID: 8510771
    [Abstract] [Full Text] [Related]

  • 16. The comparison of the responsiveness of human isolated internal mammary and gastroepiploic arteries to levcromakalim: an alternative approach to the management of graft spasm.
    Akar F, Uydeş-Dogan BS, Tufan H, Aşlamaci S, Köksoy C, Kanzik I.
    Br J Clin Pharmacol; 1997 Jul 30; 44(1):49-56. PubMed ID: 9241096
    [Abstract] [Full Text] [Related]

  • 17. Intracellular calcium and myosin light chain phosphorylation during U46619-activated vascular contraction.
    Jiang MJ, Chan CF, Chang YL.
    Life Sci; 1994 Jul 30; 54(25):2005-13. PubMed ID: 7515455
    [Abstract] [Full Text] [Related]

  • 18. Spasmolytic effect of cromakalim in dog coronary artery in vitro.
    McPherson GA, Keily SG, Angus JA.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 May 30; 343(5):519-24. PubMed ID: 1908952
    [Abstract] [Full Text] [Related]

  • 19. The thromboxane A2 and K(ATP) channel antagonist actions of a series of sulphonylurea derivatives in the pig coronary artery.
    McPherson GA, Choi RT, Kong DC, Iskander MN.
    Eur J Pharmacol; 1997 Apr 18; 324(2-3):193-200. PubMed ID: 9145771
    [Abstract] [Full Text] [Related]

  • 20. Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro.
    Kemp BK, Cocks TM.
    Br J Pharmacol; 1995 Oct 18; 116(4):2183-90. PubMed ID: 8564247
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.